| Literature DB >> 23717097 |
Mi Hyun Kim1, Young Chul Lee, Sang Yoon Choi, Chang-Won Cho, Jeonghae Rho, Kwang-Won Lee.
Abstract
In order to enhance bioactive functionalities of ginseng, an acid impregnation processing was applied as a pre-treatment in producing red ginseng. Acid impregnation studies were conducted, and acids (ascorbic, malic, and citric acid) were selected. The optimal concentration of each acid was investigated in this study in terms of ginsenoside contents. The most concerned ginsenoside, Rg3 was increased by ascorbic, malic, and citric acid pre-treated red ginseng up to 1 M acid concentration. In the case of ascorbic acid pre-treated red ginseng, Rg2 concentration was increased depending on acid concentrations. Citric acid pre-treatment enhanced Rg2, Rg3, and Rh1+Rh2 formation in red ginseng. Therefore, ginsenoside patterns in red ginseng could be changed by acid impregnation pre-treatment depending on acid concentration and acid types. This research is expected to contribute to the development of the ginseng industry via new red ginseng products with selective and intensified functionality.Entities:
Keywords: Ascorbic acid; Citric acid; Ginsenoside Rg3; Impregnation; Malic acid; Panax ginseng
Year: 2011 PMID: 23717097 PMCID: PMC3659558 DOI: 10.5142/jgr.2011.35.4.497
Source DB: PubMed Journal: J Ginseng Res ISSN: 1226-8453 Impact factor: 6.060
The changes of saponin contents in red ginseng by acid pre-treatment
| Acid treatment | Concentration (M) | Crude saponin (%) | Total saponin (%) |
|---|---|---|---|
|
| |||
| Control | 3.43 | 1.91 | |
| Ascorbic acid | 1 | 3.17 | 1.60 |
| 0.5 | 3.02 | 1.63 | |
| 0.1 | 3.23 | 1.58 | |
| Malic acid | 2 | 2.78 | 1.34 |
| 1 | 2.90 | 1.41 | |
| 0.5 | 2.88 | 1.44 | |
| 0.1 | 3.37 | 1.63 | |
| Citric acid | 2 | 3.59 | 1.90 |
| 1 | 3.24 | 1.92 | |
| 0.5 | 3.55 | 1.81 | |
| 0.1 | 3.53 | 1.91 | |
Ginsenosides content depending on malic acid concentrations (mg/g)
| Ginsenosides | Control | Malic acid concentration (M) | |||
|---|---|---|---|---|---|
|
| |||||
| 0.1 | 0.5 | 1 | 2 | ||
|
| |||||
| Rh1+Rh2 | 0.018 | 0.010 | 0.027 | 0.049 | 0.011 |
| Rg2 | 0.043 | 0.065 | 0.092 | 0.080 | 0.020 |
| Rg1 | 0.037 | 0.039 | 0.020 | 0.019 | 0.029 |
| Rg3 | 0.011 | 0.053 | 0.018 | 0.185 | 0.111 |
| Rf | 0.035 | 0.055 | 0.050 | 0.027 | 0.003 |
| Rd | 0.040 | 0.029 | 0.010 | 0.004 | 0.015 |
| Re | 0.296 | 0.215 | 0.175 | 0.208 | 0.111 |
| Rb1 | 0.144 | 0.205 | 0.016 | 0.097 | 0.081 |
| Rb2 | 0.049 | 0.055 | 0.028 | 0.019 | 0.043 |
Fig. 1.The chemical pathway of protopanaxadiol ginsenosides.
Fig. 2.The chemical pathway of protopanaxatriol ginsenosides.
Ginsenoside contents depending on ascorbic acid concentrations (mg/g)
| Ginsenosides | Control | Ascorbic acid concentration (M) | ||
|---|---|---|---|---|
|
| ||||
| 0.1 | 0.5 | 1 | ||
|
| ||||
| Rh1+Rh2 | 0.018 | 0.008 | 0.020 | 0.046 |
| Rg2 | 0.043 | 0.099 | 0.140 | 0.138 |
| Rg1 | 0.037 | 0.022 | 0.033 | 0.041 |
| Rg3 | 0.011 | 0.010 | 0.046 | 0.078 |
| Rf | 0.035 | 0.043 | 0.048 | 0.070 |
| Rd | 0.040 | 0.027 | 0.019 | 0.017 |
| Re | 0.296 | 0.198 | 0.142 | 0.127 |
| Rb1 | 0.144 | 0.103 | 0.149 | 0.193 |
| Rb2 | 0.049 | 0.040 | 0.054 | 0.069 |
Ginsenoside contents depending on citric acid concentrations (mg/g)
| Ginsenosides | Control | Citric acid concentration (M) | |||
|---|---|---|---|---|---|
|
| |||||
| 0.1 | 0.5 | 1 | 2 | ||
|
| |||||
| Rh1+Rh2 | 0.018 | 0.079 | 0.155 | 0.227 | 0.037 |
| Rg2 | 0.043 | 0.179 | 0.261 | 0.265 | 0.075 |
| Rg1 | 0.037 | 0.073 | 0.022 | 0.064 | 0.028 |
| Rg3 | 0.011 | 0.093 | 0.346 | 0.707 | 0.303 |
| Rf | 0.035 | 0.087 | 0.071 | 0.053 | 0.049 |
| Rd | 0.040 | 0.042 | 0.020 | 0.007 | 0.002 |
| Re | 0.296 | 0.315 | 0.149 | 0.055 | 0.015 |
| Rb1 | 0.144 | 0.147 | 0.120 | 0.012 | 0.024 |
| Rb2 | 0.049 | 0.093 | 0.043 | 0.025 | 0.007 |
Fig. 3.(A) The patterns of HPLC chromatogram in red ginseng ginsenosids and (B) red ginseng produced by citric acid impregnation pretreatment.